During the past decade, Carson Tahoe Regional Medical Center conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 30 clinical trials were completed, i.e. on average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 29 clinical trials were completed. i.e. 70.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carson Tahoe Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "NRG Oncology" with 13 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carson Tahoe Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Carson Tahoe Regional Medical Center" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials) and "Recurrent Ovarian Carcinoma" (5 trials). Many other conditions were trialed in "Carson Tahoe Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Carson Tahoe Regional Medical Center" are "Drug" (92 trials), "Other" (70 trials), "Biological" (49 trials), "Procedure" (40 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Quality-of-Life Assessment" (25 trials), "Biospecimen Collection" (24 trials), "Computed Tomography" (24 trials) and "Nivolumab" (20 trials). Other intervention names were less common.

The vast majority of trials in "Carson Tahoe Regional Medical Center" are 106 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Carson Tahoe Regional Medical Center". undefined are not yet recruiting, 43 are recruiting, 56 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Carson Tahoe Regional Medical Center, 4 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Carson Tahoe Regional Medical Center, 2 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Carson Tahoe Regional Medical Center has several departments that took part in Clinical trials: "Sierra Nevada Oncology Care" - 3 trials, "Carson-Tahoe Cancer Services at Carson Tahoe Regional Healthcare" - 2 trials